CANDEL THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets
CANDEL THERAPEUTICS, INC. (CADL) reported Increase (Decrease) in Other Noncurrent Assets of -$83.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2023-03-30
- CANDEL THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2021-12-31 was $0.00.
- CANDEL THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2021-09-30 was -$589.00K.
- CANDEL THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2021-06-30 was $229.00K.
- CANDEL THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2021-03-31 was $277.00K.
- CANDEL THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2021 was -$83.00K, a 200.00% decline from fiscal 2020.
- CANDEL THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2020 was $83.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$589.00K derived: sum of 2 quarters · filed 2023-03-30 | -$360.00K derived: sum of 3 quarters · filed 2023-03-30 | -$83.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$589.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$360.00K derived: sum of 2 quarters · filed 2022-11-10 | -$83.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $506.00K 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $277.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $83.00K 10-K · filed 2022-03-29 | |||
| 2020-06-30 | -$47.00K 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |